Pharmaceutical industry – Page 51

Business
$595m octreotide deal grabs Roche

2013-02-21T00:00:00Z

Company will get worldwide rights to oral formulation of growth hormone drug
Business
Merck resolves Vytorin case for $688m

2013-02-19T00:00:00Z

Investors say the company knew about Enhance trial failure but withheld information
Business
BMS sells OTC drugs for $482m

2013-02-14T00:00:00Z

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
Business
Biogen buys Tysabri from Elan for $3.25bn

2013-02-08T00:00:00Z

Elan earns huge cash injection for blockbuster drug
Business
GSK commits to AllTrials data disclosure

2013-02-07T00:00:00Z

Company will begin publishing all clinical study reports
Business
Zoetis IPO launches at $2.2bn

2013-02-01T00:00:00Z

Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
Opinion
Name reactions: how does the label stick?

2013-01-25T00:00:00Z

Derek Lowe investigates the long running tradition of naming reactions after their inventors
Business
Allergan buys MAP for $958m

2013-01-25T00:00:00Z

Deal strengthens Allergan’s position in neurology with Levadex for treating migraine
Business
Vasella to leave Novartis in August

2013-01-24T00:00:00Z

Long serving chair of the board of directors will be succeeded by Jörg Reinhardt
Business
Flu vaccine without the eggs approved

2013-01-22T00:00:00Z

Flublok does not require flu virus or eggs for manufacture
Business
India pushes for emergency drug licences

2013-01-21T00:00:00Z

Government looks set to force licensing of three patented cancer drugs
Business
BASF ups Pronova bid

2013-01-16T00:00:00Z

Pronova BioPharma specialises in omega-3 fatty acids
Business
Laropiprant recalled

2013-01-14T00:00:00Z

Merck & Co says it is recalling Tredaptive tablets, approved in the EU for treating patients with high cholesterol
Business
Pharma industry 'strategic crisis'

2013-01-11T00:00:00Z

The problem is shrinking margins, caused by price and cost pressure, regulatory change and expiring patents, report says
Business
Wellcome Trust launches investment wing

2013-01-07T00:00:00Z

Trust provides £200 million to create Syncona, which will support innovative healthcare businesses
Business
TB drug milestone for bedaquiline

2013-01-03T00:00:00Z

First TB drug with a new mechanism of action for 40 years wins approval
Business
2012 pharma industry roundup

2013-01-03T00:00:00Z

What were the bigger stories? And how did the industry fare overall?
Opinion
Fear of the unknown

2013-01-02T00:00:00Z

How do you reconcile the need for personal safety with unfamiliar compounds, asks Derek Lowe
Business
Gilead buys YM for $510m

2012-12-20T00:00:00Z

Deal gives Gilead access to Janus kinase inhibitor CYT387 for the treatment of myelofibrosis
Business
Pfizer's lost gold

2012-12-10T00:00:00Z

A stash of gold dust bought for $700,000 last year has gone missing from a Pfizer lab in St Louis, Missouri, US